Home | Phase II / III. Nimotuzumab in patients with triple-negative breast cancer.

The revisions let you track differences between multiple versions of a post.

To edit, publish or delete one of the revisions below, click on its saved date.

Published clinical_trials Phase II / III. Nimotuzumab in patients with triple-negative breast cancer. has only one revision
RevisionStatus
Saved 23/05/2014 - 1:16pm by Gladyscurrent revision (published)